Sort by
Refine Your Search
-
Category
-
Employer
- Delft University of Technology (TU Delft)
- Amsterdam UMC
- Utrecht University
- Maastricht University (UM)
- University of Amsterdam (UvA)
- Wageningen University & Research
- Eindhoven University of Technology (TU/e)
- Leiden University
- Radboud University
- University of Groningen
- Radboud University Medical Center (Radboudumc)
- Sanquin Blood Supply Foundation (Sanquin)
- Centrum Wiskunde en Informatica (CWI)
- Naturalis
- Royal Netherlands Academy of Arts and Sciences (KNAW)
- Amsterdam UMC, location VUmc
- Erasmus MC (University Medical Center Rotterdam)
- KNAW
- The Open Universiteit (OU)
- University Medical Center Groningen
- University Medical Center Utrecht (UMC Utrecht)
- University Medical Centre Groningen (UMCG)
- University of Twente
- University of Twente (UT)
- 14 more »
- « less
-
Field
-
the brain white matter. The network aims to strengthen the full translational pathway from disease mechanism and model development to preclinical therapy testing, clinical readiness and patient-informed
-
transplantation, nanotechnology, quantum sensing, mitochondrial medicine, and epigenetic editing. The project combines fundamental science with a clear path toward clinical translation, offering the opportunity
-
the brain white matter. The network aims to strengthen the full translational pathway from disease mechanism and model development to preclinical therapy testing, clinical readiness and patient-informed
-
white matter. The network aims to strengthen the full translational pathway, from understanding disease mechanisms and developing disease models to preclinical therapy testing, clinical readiness and
-
vascular models and translate the changes they show over time into pharmacokinetic and spatiotemporal models that describe how nanobubbles move through and beyond the microvasculature. The resulting
-
Doctoral Network focused on accelerating therapy development for leukodystrophies: rare genetic disorders affecting the brain's white matter. The network aims to strengthen the full translational pathway
-
white matter. The network aims to strengthen the full translational pathway, from understanding disease mechanisms and developing disease models to preclinical therapy testing, clinical readiness and
-
white matter. The network aims to strengthen the full translational pathway, from understanding disease mechanisms and developing disease models to preclinical therapy testing, clinical readiness and
-
white matter. The network aims to strengthen the full translational pathway, from understanding disease mechanisms and developing disease models to preclinical therapy testing, clinical readiness and
-
white matter. The network aims to strengthen the full translational pathway, from understanding disease mechanisms and developing disease models to preclinical therapy testing, clinical readiness and